Science Applications International Corporation (SAIC) Financials

SAIC

FY2026 annual

Revenue $7.3B -2.9% YoY

Net Income $358.0M -1.1% YoY

EPS (Diluted) $7.70 +7.4% YoY

Free Cash Flow $577.0M +26.0% YoY

Market Cap $5.6B as of Oct 10, 2026

Price / Sales 0.8x on $7.3B revenue, FY2026

Price / Earnings 15.8x on $358.0M net income, FY2026

Price / Book 3.9x on $1.4B equity, Q2 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended Jul 31, 2026 Reported Aug 31, 2026 Currency USD FYE January

Newest figures come from the 10-Q for Q2 FY2027, filed Aug 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SAIC SEC filings page.

Science Applications International Corporation (SAIC) reported $7.3B in revenue for fiscal year 2026, down 2.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SAIC FY2026 2026-10-04

Cash generation strengthened even as revenue softened, while higher debt and aggressive buybacks reshaped how shareholder returns were financed.

FY2026 operating cash flow of $609M exceeded net income of $358M, indicating that reported earnings translated into cash rather than depending mainly on non-cash accounting items. Free-cash-flow margin rose to 7.9% from 6.1% in FY2025 despite lower revenue, so the year's improvement was driven more by cash conversion than expansion.

Revenue slipped from $7.5B in FY2025 to $7.3B in FY2026, making the cash improvement look efficiency-led rather than growth-led. Gross margin held near 12.0%, but operating margin fell to 7.2%, showing that costs below gross profit absorbed some of the stable underlying economics.

Debt-to-equity increased from 1.2x in FY2025 to 1.6x in FY2026, indicating a more leveraged financing structure even though current liquidity improved. The share count fell from 47.7M to 43.4M, meaning buybacks amplified per-share results while total net income remained below the prior year's level.

Financial Health Signals

Financial Health Score 45/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Science Applications International Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Science Applications International Corporation has an operating margin of 7.2%, meaning the company retains $7 of operating profit per $100 of revenue. This strong profitability earns a score of 70/100, reflecting efficient cost management and pricing power. This is down from 7.5% the prior year.

Growth

Science Applications International Corporation's revenue declined 2.9% year-over-year, from $7.5B to $7.3B. This contraction results in a growth score of 27/100.

Leverage

Science Applications International Corporation has elevated debt relative to equity (D/E of 1.65), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 14/100, reflecting increased financial risk.

Liquidity

Science Applications International Corporation's current ratio of 1.20 is below the typical benchmark, resulting in a score of 28/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Science Applications International Corporation has a free cash flow margin of 8.0%, earning a moderate score of 53/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Science Applications International Corporation earns a strong 23.9% return on equity (ROE), meaning it generates $24 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is up from 22.9% the prior year.

Altman Z-Score Safe

2.99

Science Applications International Corporation scores 2.99, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

Science Applications International Corporation passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.70x

For every $1 of reported earnings, Science Applications International Corporation generates $1.70 in operating cash flow ($609.0M OCF vs $358.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

4.07x

Science Applications International Corporation earns $4.07 in operating income for every $1 of interest expense ($521.0M vs $128.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.9B

YoY+0.2%

QoQ+7.4%

5Y CAGR+0.7%

10Y CAGR+7.0%

Science Applications International Corporation generated $1.9B in revenue in Q2 2027. This represents an increase of 0.2% from the same quarter a year earlier. Against the prior quarter it is up 7.4%.

EBITDA

$191.0M

YoY+21.7%

QoQ+253.7%

5Y CAGR+3.9%

Science Applications International Corporation's EBITDA was $191.0M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 21.7% from the same quarter a year earlier. Against the prior quarter it is up 253.7%.

Net Income

$102.0M

YoY+50.0%

QoQ+20.0%

5Y CAGR+11.2%

10Y CAGR+11.0%

Science Applications International Corporation reported $102.0M in net income in Q2 2027. This represents an increase of 50.0% from the same quarter a year earlier. Against the prior quarter it is up 20.0%.

EPS (Diluted)

$2.38

YoY+67.6%

QoQ+26.6%

5Y CAGR+18.5%

10Y CAGR+12.2%

Science Applications International Corporation earned $2.38 per diluted share (EPS) in Q2 2027. This represents an increase of 67.6% from the same quarter a year earlier. Against the prior quarter it is up 26.6%.

Cash & Balance Sheet

Free Cash Flow

$131.0M

YoY+42.4%

QoQ-47.6%

5Y CAGR-10.0%

10Y CAGR+3.9%

Science Applications International Corporation generated $131.0M in free cash flow in Q2 2027, representing cash available after capex. This represents an increase of 42.4% from the same quarter a year earlier. Against the prior quarter it is down 47.6%.

Cash & Debt

$126.0M

YoY+168.1%

QoQ-30.8%

5Y CAGR-7.1%

10Y CAGR-8.3%

Science Applications International Corporation held $126.0M in cash against $2.5B in long-term debt as of Q2 2027.

Dividends Per Share

$0.37

YoY0.0%

QoQ+150.0%

5Y CAGR0.0%

10Y CAGR+2.8%

Science Applications International Corporation paid $0.37 per share in dividends in Q2 2027. That is unchanged from the same quarter a year earlier. Against the prior quarter it is up 150.0%.

Shares Outstanding

42M

YoY-10.6%

QoQ-3.5%

5Y CAGR-6.4%

10Y CAGR-0.8%

Science Applications International Corporation had 42M shares outstanding in Q2 2027. This represents a decrease of 10.6% from the same quarter a year earlier. Against the prior quarter it is down 3.5%.

Margins & Returns

Gross Margin

12.7%

YoY+1.6pp

QoQ+0.1pp

5Y change+1.2pp

Science Applications International Corporation's gross margin was 12.7% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Operating Margin

8.1%

YoY+1.6pp

QoQ+0.5pp

5Y change+2.0pp

10Y change+1.9pp

Science Applications International Corporation's operating margin was 8.1% in Q2 2027, reflecting core business profitability. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.

Net Margin

5.4%

YoY+1.8pp

QoQ+0.6pp

5Y change+2.1pp

10Y change+1.7pp

Science Applications International Corporation's net profit margin was 5.4% in Q2 2027, showing the share of revenue converted to profit. This is up 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Return on Equity

7.1%

YoY+2.6pp

QoQ+1.4pp

5Y change+3.1pp

10Y change-3.3pp

Science Applications International Corporation's ROE was 7.1% in Q2 2027, measuring profit generated per dollar of shareholder equity. This is up 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Capital Allocation

Share Buybacks

$98.0M

YoY-31.0%

QoQ0.0%

5Y CAGR+150.2%

10Y CAGR+14.2%

Science Applications International Corporation spent $98.0M on share buybacks in Q2 2027, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 31.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Capital Expenditures

$15.0M

YoY+87.5%

QoQ+87.5%

5Y CAGR+10.8%

10Y CAGR+7.9%

Science Applications International Corporation invested $15.0M in capex in Q2 2027, funding long-term assets and infrastructure. This represents an increase of 87.5% from the same quarter a year earlier. Against the prior quarter it is up 87.5%.

R&D Spending

Not reported for Q2 2027.

SAIC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SAIC quarterly income statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$7.3B-2.9%	$7.5B+0.5%	$7.4B-3.4%	$7.7B+4.2%	$7.4B+4.8%	$7.1B+10.6%	$6.4B+36.9%	$4.7B+4.6%	$4.5B+0.3%	$4.4B+2.9%	$4.3B+11.1%	$3.9B-5.7%	$4.1B-13.8%	$4.8B+1.0%	$4.7B
Cost of Revenue	$6.4B-3.0%	$6.6B+0.2%	$6.6B-3.6%	$6.8B+4.3%	$6.5B+4.3%	$6.3B+10.4%	$5.7B+35.2%	$4.2B+3.8%	$4.0B+1.0%	$4.0B+2.5%	$3.9B+10.0%	$3.5B-6.3%	$3.8B-13.4%	$4.4B+1.5%	$4.3B
Gross Profit	$872.0M-2.2%	$892.0M+2.3%	$872.0M-1.8%	$888.0M+3.4%	$859.0M+8.5%	$792.0M+12.2%	$706.0M+52.2%	$464.0M+12.9%	$411.0M-6.4%	$439.0M+6.8%	$411.0M+22.7%	$335.0M+0.6%	$333.0M-18.4%	$408.0M-4.2%	$426.0M
R&D Expenses	$13.0M+8.3%	$12.0M+200.0%	$4.0M+300.0%	$1.0M-75.0%	$4.0M-33.3%	$6.0M-14.3%	$7.0M+40.0%	$5.0M+25.0%	$4.0M0.0%	$4.0M0.0%	$4.0M-20.0%	$5.0M+25.0%	$4.0M+33.3%	$3.0M-62.5%	$8.0M
SG&A Expenses	$350.0M+3.2%	$339.0M-9.1%	$373.0M-0.3%	$374.0M+8.7%	$344.0M-2.3%	$352.0M+22.2%	$288.0M+82.3%	$158.0M+1.9%	$155.0M-6.6%	$166.0M-9.8%	$184.0M+93.7%	$95.0M+3.3%	$92.0M-7.1%	$99.0M-22.0%	$127.0M
Operating Income	$521.0M-7.5%	$563.0M-24.0%	$741.0M+47.9%	$501.0M+8.4%	$462.0M+18.5%	$390.0M+5.4%	$370.0M+68.2%	$220.0M-14.1%	$256.0M-2.7%	$263.0M+15.9%	$227.0M-5.4%	$240.0M+31.1%	$183.0M-34.9%	$281.0M-6.0%	$299.0M
EBITDA	$551.0M-6.3%	$588.0M-23.3%	$767.0M+43.9%	$533.0M+6.8%	$499.0M+18.2%	$422.0M+3.9%	$406.0M+67.1%	$243.0M-12.9%	$279.0M-2.4%	$286.0M+13.0%	$253.0M-2.3%	$259.0M+33.5%	$194.0M-33.3%	$291.0M-7.3%	$314.0M
Interest Expense	$128.0M+1.6%	$126.0M+5.0%	$120.0M0.0%	$120.0M+14.3%	$105.0M-13.9%	$122.0M+35.6%	$90.0M+69.8%	$53.0M+20.5%	$44.0M-15.4%	$52.0M+18.2%	$44.0M+158.8%	$17.0M+142.9%	$7.0M	N/A	N/A
Income Tax	$29.0M-56.1%	$66.0M-53.8%	$143.0M+98.6%	$72.0M-8.9%	$79.0M+31.7%	$60.0M+5.3%	$57.0M+72.7%	$33.0M-5.7%	$35.0M-49.3%	$69.0M+4.5%	$66.0M-19.5%	$82.0M+30.2%	$63.0M-36.4%	$99.0M-14.7%	$116.0M
Net Income	$358.0M-1.1%	$362.0M-24.1%	$477.0M+57.4%	$303.0M+8.6%	$279.0M+33.5%	$209.0M-7.5%	$226.0M+65.0%	$137.0M-23.5%	$179.0M+25.2%	$143.0M+22.2%	$117.0M-17.0%	$141.0M+24.8%	$113.0M-37.9%	$182.0M0.0%	$182.0M
EPS (Basic)	$7.73+6.9%	$7.23-19.5%	$8.98+65.7%	$5.42+12.7%	$4.81+33.6%	$3.60-7.0%	$3.87+22.5%	$3.16-23.5%	$4.13+28.7%	$3.21+25.9%	$2.55-15.3%	$3.01+29.2%	$2.33-37.7%	$3.740.0%	$3.74
EPS (Diluted)	$7.70+7.4%	$7.17-19.3%	$8.88+65.1%	$5.38+12.8%	$4.77+34.0%	$3.56-7.0%	$3.83+23.2%	$3.11-22.6%	$4.02+28.8%	$3.12+26.3%	$2.47-15.1%	$2.91+28.2%	$2.27-38.0%	$3.660.0%	$3.66
Diluted Shares (Avg)	47M-7.9%	51M-6.0%	54M-3.8%	56M-4.0%	58M-1.0%	59M-0.5%	59M+33.8%	44M-0.9%	45M-3.1%	46M-3.2%	47M-2.3%	49M-2.4%	50M0.0%	50M0.0%	50M

Metric	Q2'2710-Q	Q4'2610-Q	Q3'2610-K	Q2'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-K
Revenue	$1.9B+0.2%	$1.8B-11.4%	$1.9B+2.6%	$1.9B+1.6%	$2.0B+4.3%	$1.8B+1.9%	$1.8B-8.9%	$1.9B-0.9%
Cost of Revenue	$1.6B-1.6%	$1.5B-12.1%	$1.6B+1.9%	$1.7B+2.1%	$1.7B+4.4%	$1.6B+2.6%	$1.6B-8.9%	$1.7B-1.1%
Gross Profit	$239.0M+14.4%	$221.0M-6.8%	$227.0M+8.1%	$209.0M-1.9%	$237.0M+3.5%	$210.0M-2.8%	$213.0M-9.4%	$214.0M+0.5%
SG&A Expenses	$87.0M-2.2%	$85.0M+2.4%	$101.0M+31.2%	$89.0M+4.7%	$83.0M-4.6%	$77.0M-12.5%	$85.0M+1.2%	$113.0M+2.7%
Operating Income	$152.0M+25.6%	$133.0M-16.9%	$128.0M-4.5%	$121.0M-7.6%	$160.0M+11.9%	$134.0M-63.0%	$131.0M-16.6%	$105.0M+22.1%
EBITDA	$191.0M+21.7%	$54.0M-72.3%	$166.0M-15.7%	$157.0M-5.4%	$195.0M+10.2%	$197.0M-50.5%	$166.0M-14.0%	$26.0M+420.0%
Interest Expense	$33.0M+10.0%	$34.0M+6.3%	$33.0M+6.5%	$30.0M-11.8%	$32.0M+18.5%	$31.0M+6.9%	$34.0M+6.3%	$30.0M+7.1%
Income Tax	$17.0M-5.6%	$14.0M-30.0%	$16.0M-15.8%	$18.0M0.0%	$20.0M-4.8%	$19.0M-78.4%	$18.0M-28.0%	$16.0M+166.7%
Net Income	$102.0M+50.0%	$85.0M-19.8%	$78.0M-3.7%	$68.0M-11.7%	$106.0M+14.0%	$81.0M-67.2%	$77.0M-21.4%	$60.0M+15.4%
EPS (Basic)	$2.41+68.5%	$1.88-12.6%	$1.70+6.9%	$1.43-4.0%	$2.15+20.1%	$1.59-65.4%	$1.49-17.2%	$0.79-41.9%
EPS (Diluted)	$2.38+67.6%	$1.88-11.7%	$1.69+7.0%	$1.42-4.1%	$2.13+21.0%	$1.58-65.4%	$1.48-17.3%	$0.77
Diluted Shares (Avg)	43M-10.5%	N/A	46M-10.0%	48M-8.3%	50M-6.6%	51M-5.0%	52M-4.9%	N/A

Not reported in any period shown, so not listed: R&D Expenses.

SAIC Balance Sheet

SAIC quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$5.4B+2.1%	$5.2B-1.3%	$5.3B-4.1%	$5.5B-3.5%	$5.7B+0.4%	$5.7B+21.5%	$4.7B+3.2%	$4.6B+120.1%	$2.1B+1.5%	$2.0B-3.8%	$2.1B+52.8%	$1.4B-4.0%	$1.4B+16.2%	$1.2B	N/A
Current Assets	$1.2B+2.2%	$1.2B+2.0%	$1.1B-5.5%	$1.2B-5.2%	$1.3B-2.0%	$1.3B-9.9%	$1.4B-0.2%	$1.4B+50.8%	$950.0M+5.4%	$901.0M-5.4%	$952.0M+1.1%	$942.0M-5.2%	$994.0M+22.9%	$809.0M	N/A
Cash & Equivalents	$182.0M+225.0%	$56.0M-40.4%	$94.0M-13.8%	$109.0M+2.8%	$106.0M-38.0%	$171.0M-9.0%	$188.0M-20.7%	$237.0M+64.6%	$144.0M-31.4%	$210.0M+7.7%	$195.0M-35.2%	$301.0M+18.5%	$254.0M+25300.0%	$1.0M0.0%	$1.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	$3.0M-95.8%	$71.0M+10.9%	$64.0M-17.9%	$78.0M-7.1%	$84.0M+13.5%	$74.0M+8.8%	$68.0M-4.2%	$71.0M+4.4%	$68.0M+1.5%	$67.0M+13.6%	$59.0M-37.2%	$94.0M	N/A
Accounts Receivable	$853.0M-14.7%	$1.0B+9.4%	$914.0M-2.4%	$936.0M-7.8%	$1.0B+5.5%	$962.0M-12.5%	$1.1B+4.7%	$1.1B+55.8%	$674.0M+25.0%	$539.0M-15.1%	$635.0M+16.7%	$544.0M-12.4%	$621.0M-10.1%	$691.0M	N/A
Long-Term Investments	$0-100.0%	$36.0M+12.5%	$32.0M+14.3%	$28.0M0.0%	$28.0M+3.7%	$27.0M0.0%	$27.0M+575.0%	$4.0M	$0	$0	$0	$0	$0	$0	$0
Goodwill	$2.9B+3.3%	$2.9B0.0%	$2.9B-2.1%	$2.9B-0.1%	$2.9B+4.5%	$2.8B+30.3%	$2.1B+0.9%	$2.1B+145.7%	$863.0M0.0%	$863.0M+0.3%	$860.0M+126.9%	$379.0M0.0%	$379.0M0.0%	$379.0M	N/A
Total Liabilities	$3.9B+5.0%	$3.7B+4.0%	$3.5B-8.3%	$3.8B-6.7%	$4.1B-1.3%	$4.2B+26.9%	$3.3B+7.0%	$3.1B+76.3%	$1.7B+3.1%	$1.7B-2.8%	$1.7B+66.9%	$1.0B-2.4%	$1.1B+64.9%	$649.0M	N/A
Current Liabilities	$982.0M-29.7%	$1.4B+20.6%	$1.2B+2.8%	$1.1B-16.7%	$1.4B+6.0%	$1.3B+13.0%	$1.1B+25.8%	$897.0M+29.1%	$695.0M+11.6%	$623.0M-9.4%	$688.0M+24.6%	$552.0M-2.1%	$564.0M-11.6%	$638.0M	N/A
Non-Current Liabilities	$2.9B+26.4%	$2.3B-4.1%	$2.4B-12.9%	$2.7B-1.9%	$2.8B-4.5%	$2.9B+34.2%	$2.2B-0.7%	$2.2B+107.5%	$1.1B-1.8%	$1.1B+1.5%	$1.1B+114.2%	$492.0M-2.8%	$506.0M+4500.0%	$11.0M	N/A
Long-Term Debt	$2.5B+29.4%	$1.9B-5.7%	$2.0B-13.7%	$2.3B-1.1%	$2.4B-3.1%	$2.4B+32.2%	$1.9B-10.4%	$2.1B+110.1%	$983.0M-3.8%	$1.0B+0.9%	$1.0B+123.1%	$454.0M-7.2%	$489.0M+48800.0%	$1.0M0.0%	$1.0M
Total Equity	$1.5B-4.9%	$1.6B-11.7%	$1.8B+5.4%	$1.7B+4.6%	$1.6B+5.0%	$1.5B+8.8%	$1.4B-4.6%	$1.5B+354.1%	$327.0M-6.3%	$349.0M-8.2%	$380.0M+10.1%	$345.0M-8.5%	$377.0M-36.7%	$596.0M-9.1%	$656.0M
Retained Earnings	$1.5B-4.7%	$1.6B+9.3%	$1.4B+38.4%	$1.0B+26.5%	$818.0M+30.5%	$627.0M+23.9%	$506.0M+37.9%	$367.0M+13.6%	$323.0M+24.2%	$260.0M+49.4%	$174.0M+50.0%	$116.0M+286.7%	$30.0M	N/A	N/A

Metric	Q2'2710-Q	Q4'2610-Q	Q3'2610-K	Q2'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-K
Total Assets	$5.4B+4.1%	$5.4B+1.5%	$5.4B+3.3%	$5.2B-0.7%	$5.3B-6.8%	$5.3B-7.4%	$5.3B-11.9%	$5.3B-4.1%
Current Assets	$1.3B+11.4%	$1.2B+1.6%	$1.3B+14.0%	$1.1B+5.2%	$1.2B-16.4%	$1.1B-20.3%	$1.1B-34.9%	$1.1B-5.5%
Cash & Equivalents	$126.0M+168.1%	$182.0M+295.7%	$45.0M-6.3%	$47.0M-4.1%	$46.0M-85.2%	$48.0M-86.4%	$49.0M-88.4%	$94.0M-13.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$3.0M-95.8%
Accounts Receivable	$996.0M-1.3%	$853.0M-16.5%	$1.0B+10.5%	$1.0B+8.0%	$1.0B+1.2%	$946.0M-1.3%	$934.0M-6.1%	$914.0M-2.4%
Long-Term Investments	$0-100.0%	$0-100.0%	$39.0M+8.3%	$35.0M+9.4%	$36.0M+24.1%	$36.0M+20.0%	$32.0M+10.3%	$32.0M+14.3%
Goodwill	$2.9B+3.2%	$2.9B+3.3%	$3.0B+3.8%	$2.9B0.0%	$2.9B0.0%	$2.9B0.0%	$2.9B0.0%	$2.9B-2.1%
Total Liabilities	$4.0B+7.6%	$3.9B+5.2%	$3.9B+7.9%	$3.7B+6.2%	$3.7B-4.4%	$3.6B-5.3%	$3.5B-18.1%	$3.5B-8.3%
Current Liabilities	$1.1B-28.0%	$982.0M-26.6%	$1.1B-18.7%	$1.5B+27.7%	$1.3B+9.1%	$1.3B+6.6%	$1.2B-25.7%	$1.2B+2.8%
Non-Current Liabilities	$2.9B+31.0%	$2.9B+23.5%	$2.9B+22.6%	$2.2B-4.5%	$2.3B-10.7%	$2.3B-10.9%	$2.3B-13.8%	$2.4B-12.9%
Long-Term Debt	$2.5B+30.7%	$2.5B+27.3%	$2.5B+25.6%	$1.9B-5.9%	$1.9B-11.6%	$2.0B-11.1%	$2.0B-14.4%	$2.0B-13.7%
Total Equity	$1.4B-4.6%	$1.5B-6.9%	$1.5B-7.0%	$1.5B-14.4%	$1.6B-11.8%	$1.6B-11.8%	$1.8B+4.0%	$1.8B+5.4%
Retained Earnings	$1.4B-4.4%	$1.5B-6.9%	$1.5B-3.0%	$1.5B+0.3%	$1.6B+13.4%	$1.6B+15.7%	$1.5B+33.8%	$1.4B+38.4%

SAIC Cash Flow Statement

SAIC quarterly cash flow statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$609.0M+23.3%	$494.0M+24.7%	$396.0M-25.6%	$532.0M+2.7%	$518.0M-31.4%	$755.0M+64.8%	$458.0M+148.9%	$184.0M-15.2%	$217.0M-20.5%	$273.0M+20.8%	$226.0M-18.4%	$277.0M+51.4%	$183.0M-34.6%	$280.0M-7.6%	$303.0M
Depreciation & Amortization	$30.0M+20.0%	$25.0M-3.8%	$26.0M-18.8%	$32.0M-13.5%	$37.0M+15.6%	$32.0M-11.1%	$36.0M+56.5%	$23.0M0.0%	$23.0M0.0%	$23.0M-11.5%	$26.0M+36.8%	$19.0M+72.7%	$11.0M+10.0%	$10.0M-33.3%	$15.0M
Stock-Based Compensation	$64.0M+20.8%	$53.0M-22.1%	$68.0M+41.7%	$48.0M+4.3%	$46.0M+9.5%	$42.0M+13.5%	$37.0M-17.8%	$45.0M+66.7%	$27.0M-12.9%	$31.0M-6.1%	$33.0M-5.7%	$35.0M+6.1%	$33.0M+10.0%	$30.0M+7.1%	$28.0M
Capital Expenditures	$32.0M-11.1%	$36.0M+33.3%	$27.0M+8.0%	$25.0M-30.6%	$36.0M-21.7%	$46.0M+119.0%	$21.0M-25.0%	$28.0M+27.3%	$22.0M+46.7%	$15.0M-25.0%	$20.0M-9.1%	$22.0M+37.5%	$16.0M+128.6%	$7.0M+16.7%	$6.0M
Free Cash Flow	$577.0M+26.0%	$458.0M+24.1%	$369.0M-27.2%	$507.0M+5.2%	$482.0M-32.0%	$709.0M+62.2%	$437.0M+180.1%	$156.0M-20.0%	$195.0M-24.4%	$258.0M+25.2%	$206.0M-19.2%	$255.0M+52.7%	$167.0M-38.8%	$273.0M-8.1%	$297.0M
Investing Cash Flow	-$248.0M-608.6%	-$35.0M-111.1%	$314.0M+972.2%	-$36.0M+87.7%	-$292.0M+76.3%	-$1.2B-2519.1%	-$47.0M+95.4%	-$1.0B-4572.7%	-$22.0M-29.4%	-$17.0M+97.8%	-$784.0M	N/A	N/A	N/A	N/A
Financing Cash Flow	-$235.0M+52.8%	-$498.0M+31.3%	-$725.0M-47.1%	-$493.0M-63.8%	-$301.0M-164.9%	$464.0M+202.0%	-$455.0M-148.5%	$938.0M+459.4%	-$261.0M-5.7%	-$247.0M-153.0%	$466.0M	N/A	N/A	N/A	N/A
Dividends Paid	$70.0M-6.7%	$75.0M-5.1%	$79.0M-4.8%	$83.0M-3.5%	$86.0M-1.1%	$87.0M0.0%	$87.0M+64.2%	$53.0M-1.9%	$54.0M0.0%	$54.0M-1.8%	$55.0M+5.8%	$52.0M-82.4%	$295.0M	N/A	N/A
Share Buybacks	$445.0M-20.3%	$558.0M+46.1%	$382.0M+43.1%	$267.0M+18.1%	$226.0M+564.7%	$34.0M-82.7%	$197.0M+185.5%	$69.0M-62.9%	$186.0M+3.3%	$180.0M+160.9%	$69.0M-53.7%	$149.0M+1046.2%	$13.0M	N/A	N/A

Metric	Q2'2710-Q	Q4'2610-Q	Q3'2610-K	Q2'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-K
Operating Cash Flow	$146.0M+46.0%	$258.0M+80.4%	$129.0M-6.5%	$100.0M+2.0%	$143.0M+41.6%	$138.0M-8.0%	$98.0M+19.5%	$63.0M-56.6%
Depreciation & Amortization	$39.0M+8.3%	-$79.0M-325.7%	$38.0M-39.7%	$36.0M+2.9%	$35.0M+2.9%	$63.0M+75.0%	$35.0M-2.8%	-$79.0M+2.5%
Stock-Based Compensation	N/A	N/A	N/A	$15.0M+15.4%	N/A	N/A	$13.0M+8.3%	N/A
Capital Expenditures	$15.0M+87.5%	$8.0M-11.1%	$9.0M+50.0%	$8.0M+33.3%	$9.0M+125.0%	$6.0M0.0%	$6.0M0.0%	$11.0M+57.1%
Free Cash Flow	$131.0M+42.4%	$250.0M+86.6%	$120.0M-9.1%	$92.0M0.0%	$134.0M+38.1%	$132.0M-8.3%	$92.0M+21.1%	$52.0M-62.3%
Investing Cash Flow	-$15.0M0.0%	-$11.0M-1200.0%	-$215.0M-2288.9%	-$15.0M-114.3%	$1.0M+110.0%	-$9.0M-350.0%	-$7.0M-102.1%	-$10.0M+23.1%
Financing Cash Flow	-$114.0M-21.3%	-$110.0M+24.7%	$83.0M+163.4%	-$94.0M+30.9%	-$146.0M-10.6%	-$131.0M+39.9%	-$136.0M-29.5%	-$270.0M-255.3%
Dividends Paid	$16.0M-15.8%	$17.0M-5.6%	$17.0M-10.5%	$19.0M-5.0%	$18.0M-5.3%	$19.0M-5.0%	$20.0M-4.8%	$19.0M-5.0%
Share Buybacks	$98.0M-31.0%	$98.0M-19.0%	$95.0M-52.7%	$142.0M+37.9%	$121.0M+17.5%	$201.0M+97.1%	$103.0M+17.0%	$89.0M+50.8%

SAIC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SAIC quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	12.0%+0.1pp	11.9%+0.2pp	11.7%+0.2pp	11.5%-0.1pp	11.6%+0.4pp	11.2%+0.1pp	11.1%+1.1pp	10.0%+0.7pp	9.2%-0.7pp	9.9%+0.4pp	9.5%+0.9pp	8.6%+0.5pp	8.1%-0.5pp	8.5%-0.5pp	9.0%
Operating Margin	7.2%-0.4pp	7.5%-2.4pp	10.0%+3.5pp	6.5%+0.3pp	6.3%+0.7pp	5.5%-0.3pp	5.8%+1.1pp	4.7%-1.0pp	5.8%-0.2pp	5.9%+0.7pp	5.3%-0.9pp	6.2%+1.7pp	4.4%-1.4pp	5.9%-0.4pp	6.3%
Net Margin	4.9%+0.1pp	4.8%-1.6pp	6.4%+2.5pp	3.9%+0.2pp	3.8%+0.8pp	3.0%-0.6pp	3.5%+0.6pp	2.9%-1.1pp	4.0%+0.8pp	3.2%+0.5pp	2.7%-0.9pp	3.6%+0.9pp	2.7%-1.1pp	3.8%0.0pp	3.9%
Return on Equity	23.9%+0.9pp	22.9%-3.8pp	26.7%+8.8pp	17.9%+0.7pp	17.2%+3.7pp	13.6%-2.4pp	16.0%+6.7pp	9.2%-45.5pp	54.7%+13.8pp	41.0%+10.2pp	30.8%-10.1pp	40.9%+10.9pp	30.0%-0.6pp	30.5%+2.8pp	27.7%
Return on Assets	6.7%-0.2pp	6.9%-2.1pp	9.0%+3.5pp	5.5%+0.6pp	4.9%+1.2pp	3.6%-1.2pp	4.8%+1.8pp	3.0%-5.6pp	8.6%+1.6pp	7.0%+1.5pp	5.5%-4.6pp	10.2%+2.3pp	7.8%-6.8pp	14.6%	N/A
Current Ratio	1.20+0.4x	0.83-0.2x	0.98-0.1x	1.06+0.1x	0.93-0.1x	1.01-0.3x	1.27-0.3x	1.60+0.2x	1.37-0.1x	1.45+0.1x	1.38-0.3x	1.71-0.1x	1.76+0.5x	1.27	N/A
Debt-to-Equity	1.65+0.4x	1.21+0.1x	1.13-0.3x	1.38-0.1x	1.46-0.1x	1.59+0.3x	1.31-0.1x	1.39-1.6x	3.01+0.1x	2.93+0.3x	2.67+1.3x	1.320.0x	1.30+1.3x	0.000.0x	0.00
Asset Turnover	1.36-0.1x	1.430.0x	1.400.0x	1.39+0.1x	1.29+0.1x	1.23-0.1x	1.35+0.3x	1.02-1.1x	2.150.0x	2.18+0.1x	2.03-0.8x	2.80-0.1x	2.85-1.0x	3.84	N/A
FCF Margin	8.0%+1.8pp	6.1%+1.2pp	5.0%-1.6pp	6.6%+0.1pp	6.5%-3.5pp	10.1%+3.2pp	6.9%+3.5pp	3.4%-1.0pp	4.4%-1.4pp	5.8%+1.0pp	4.8%-1.8pp	6.6%+2.5pp	4.0%-1.7pp	5.7%-0.6pp	6.3%

Metric	Q2'2710-Q	Q4'2610-Q	Q3'2610-K	Q2'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-K
Gross Margin	12.7%+1.6pp	12.6%+0.6pp	12.2%+0.6pp	11.1%-0.4pp	12.0%-0.1pp	11.6%-0.6pp	11.5%-0.1pp	11.2%+0.2pp
Operating Margin	8.1%+1.6pp	7.6%-0.5pp	6.9%-0.5pp	6.5%-0.6pp	8.1%+0.6pp	7.4%-12.9pp	7.1%-0.6pp	5.5%+1.0pp
Net Margin	5.4%+1.8pp	4.9%-0.5pp	4.2%-0.3pp	3.6%-0.5pp	5.4%+0.5pp	4.5%-9.4pp	4.2%-0.7pp	3.1%+0.4pp
Return on Equity	7.1%+2.6pp	5.7%-0.9pp	5.2%+0.2pp	4.5%+0.1pp	6.6%+1.5pp	5.0%-8.4pp	4.4%-1.4pp	3.4%+0.3pp
Return on Assets	1.9%+0.6pp	1.6%-0.4pp	1.4%-0.1pp	1.3%-0.2pp	2.0%+0.4pp	1.5%-2.8pp	1.5%-0.2pp	1.1%+0.2pp
Current Ratio	1.20+0.4x	1.20+0.3x	1.20+0.3x	0.78-0.2x	0.87-0.3x	0.85-0.3x	0.95-0.1x	0.98-0.1x
Debt-to-Equity	1.71+0.5x	1.65+0.4x	1.64+0.4x	1.25+0.1x	1.200.0x	1.210.0x	1.13-0.2x	1.13-0.3x
Asset Turnover	0.350.0x	0.330.0x	0.340.0x	0.360.0x	0.370.0x	0.350.0x	0.350.0x	0.360.0x
FCF Margin	7.0%+2.1pp	14.3%+7.5pp	6.4%-0.8pp	4.9%-0.1pp	6.8%+1.7pp	7.3%-0.8pp	5.0%+1.2pp	2.7%-4.4pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Science Applications International Corporation SAIC	FY2026	$7.3B	$358.0M	4.9%	$5.6B	45/100
Applied Digital Corporation APLD	FY2026	$611.3M	-$250.3M	-40.9%	$7.2B	40/100
Ingram Micro Holding Corporation INGM	FY2025	$52.6B	$327.9M	0.6%	$6.4B	50/100
Parsons Corporation PSN	FY2025	$6.4B	$241.1M	3.8%	$4.8B	55/100
Pony AI Inc. PONY	FY2025	$90.0M	-$134.0M	N/A	$2.6B	64/100
Verra Mobility Corporation VRRM	FY2025	$979.1M	$136.6M	14.0%	$446.8M	65/100

Where Science Applications International Corporation Ranks

Frequently Asked Questions

What is Science Applications International Corporation's annual revenue?

Science Applications International Corporation (SAIC) reported $7.3B in total revenue for fiscal year 2026. This represents a -2.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Science Applications International Corporation's revenue growing?

Science Applications International Corporation (SAIC) revenue declined by 2.9% year-over-year, from $7.5B to $7.3B in fiscal year 2026.

Is Science Applications International Corporation profitable?

Yes, Science Applications International Corporation (SAIC) reported a net income of $358.0M in fiscal year 2026, with a net profit margin of 4.9%.

What is Science Applications International Corporation's EBITDA?

Science Applications International Corporation (SAIC) had EBITDA of $551.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Science Applications International Corporation have?

As of fiscal year 2026, Science Applications International Corporation (SAIC) had $182.0M in cash and equivalents against $2.5B in long-term debt.

What is Science Applications International Corporation's gross margin?

Science Applications International Corporation (SAIC) had a gross margin of 12.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Science Applications International Corporation's operating margin?

Science Applications International Corporation (SAIC) had an operating margin of 7.2% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Science Applications International Corporation's net profit margin?

Science Applications International Corporation (SAIC) had a net profit margin of 4.9% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Science Applications International Corporation pay dividends?

Yes, Science Applications International Corporation (SAIC) paid $0.37 per share in dividends during fiscal year 2026.

What is Science Applications International Corporation's return on equity (ROE)?

Science Applications International Corporation (SAIC) has a return on equity of 23.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Science Applications International Corporation's free cash flow?

Science Applications International Corporation (SAIC) generated $577.0M in free cash flow during fiscal year 2026. This represents a 26.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Science Applications International Corporation's operating cash flow?

Science Applications International Corporation (SAIC) generated $609.0M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Science Applications International Corporation's total assets?

Science Applications International Corporation (SAIC) had $5.4B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Science Applications International Corporation's capital expenditures?

Science Applications International Corporation (SAIC) invested $32.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Science Applications International Corporation spend on research and development?

Science Applications International Corporation (SAIC) invested $13.0M in research and development during fiscal year 2026.

Does Science Applications International Corporation buy back shares?

Yes, Science Applications International Corporation (SAIC) spent $445.0M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Science Applications International Corporation have outstanding?

Science Applications International Corporation (SAIC) had 43M shares outstanding as of fiscal year 2026.

What is Science Applications International Corporation's current ratio?

Science Applications International Corporation (SAIC) had a current ratio of 1.20 as of fiscal year 2026, which is considered adequate.

What is Science Applications International Corporation's debt-to-equity ratio?

Science Applications International Corporation (SAIC) had a debt-to-equity ratio of 1.65 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Science Applications International Corporation's return on assets (ROA)?

Science Applications International Corporation (SAIC) had a return on assets of 6.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Science Applications International Corporation's P/E ratio?

Science Applications International Corporation (SAIC) trades at 15.8x earnings, its market capitalization divided by net income of $358.0M net income, FY2026. The market capitalization is $5.6B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Science Applications International Corporation's price-to-sales ratio?

Science Applications International Corporation (SAIC) trades at 0.8x sales, its market capitalization divided by revenue of $7.3B revenue, FY2026. The market capitalization is $5.6B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Science Applications International Corporation's Altman Z-Score?

Science Applications International Corporation (SAIC) has an Altman Z-Score of 2.99, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Science Applications International Corporation's Piotroski F-Score?

Science Applications International Corporation (SAIC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Science Applications International Corporation's earnings high quality?

Science Applications International Corporation (SAIC) has an earnings quality ratio of 1.70x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Science Applications International Corporation cover its interest payments?

Science Applications International Corporation (SAIC) has an interest coverage ratio of 4.07x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Science Applications International Corporation?

Science Applications International Corporation (SAIC) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.